100 research outputs found
WLL Project Evaluation and Learning
Welcome to the concluding final evaluation and learning report for the Womenâs Lives Leeds (WLL) Project. The Womenâs Lives Leeds (WLL) Project was a Big Lottery, since renamed National Lottery Community Fund (NLCF), Women and Girls Initiative Funded 4-year Project that delivered a range of opportunities including frontline services that enabled women and girls to lead safer and healthier lives and was created by a partnership of Womenâs led and centred organisations in Leeds, who joined together to form the âWLL Partnershipâ in May 2015. The Partnership included Asha Neighbourhood Centre, Basis Yorkshire, Behind Closed Doors, Getaway Girls, Hooner Kelah, Leeds Womenâs Aid, HALT (who have since merged with LWA), Nari Ekta, Shantona Womenâs Centre, Together Women, Womenâs Counselling and Therapy Service, and Womenâs Health Matters. Between them they have a collective of over 250 yearsâ experience supporting the most vulnerable women and girls across the city of Leeds who experience multiple needs including; mental health, domestic abuse, sexual violence and exploitation, experience of the criminal justice system, sex work and substance misuse. The focus of the work was on providing support to the most disadvantaged communities in Leeds, with the aim of reaching greater numbers of the most vulnerable women, ensuring they receive holistic, joined-up support no matter where in the city they live. As one, they applied to the Big Lotteryâs, Womenâs and Girls Initiative fund, to fund the WLL Project and later that year were successful. The partnership was granted over ÂŁ2.2mil over a 4-year timescale. The WLL Project focussed on Women, Young Women and Girls and identified specific target groups: young women, women with complex needs and recently arrived new migrant communities and was based on initial research completed in December 2015 that identified current needs. The Project aimed to achieve the following 3 outcomes: 1. Improved and extended access for vulnerable women and girls in Leeds to the services and support they want, when they choose 2. A holistic response to ensure that the needs of women and girls with multiple and complex issues are better supported 3. Women and Girls will be empowered to support their peers and influence service delivery, development and design across the city The Executive Summary was completed in November 2020 and has already been shared with all stakeholders, partners and commissioners including Leeds City Council, Public Health and Clinical Commissioning Groups. The purpose of this report is to detail the learning, challenges and successes taken from project delivery throughout its lifespan and its achievements with the aim for this to be shared to inform other providers in their service development. This report has been informed by views from service users, external stakeholders, ongoing external evaluation, staff and the WLL Alliance gathered over the last four years
A RIPE3b1-like factor binds to a novel site in the human insulin promoter in a redox-dependent manner
AbstractIn the human insulin gene, a regulatory sequence upstream of the transcription start site at â229 to â258 (the E2 element) binds a ubiquitous factor USF. The present study led to the identification of a second factor, D0, that binds to an adjacent upstream site, the C2 element, that has previously not been described. The results demonstrate that D0 exhibits similar properties to RIPE3b1, a factor shown to be an important determinant of insulin gene β-cell-specific expression. Binding of D0 to the C2 element was abolished by the oxidising agent diamide, and the alkylating agent N-ethylmaleimide. The results indicate that expression of the insulin gene may be regulated by a redox-dependent pathway involving RIPE3b1 or a RIPE3b1-like factor
Recessive mutations in the INS gene result in neonatal diabetes through reduced insulin biosynthesis
Heterozygous coding mutations in the INS gene that encodes preproinsulin were recently shown to be an important cause of permanent neonatal diabetes. These dominantly acting mutations prevent normal folding of proinsulin, which leads to beta-cell death through endoplasmic reticulum stress and apoptosis. We now report 10 different recessive INS mutations in 15 probands with neonatal diabetes. Functional studies showed that recessive mutations resulted in diabetes because of decreased insulin biosynthesis through distinct mechanisms, including gene deletion, lack of the translation initiation signal, and altered mRNA stability because of the disruption of a polyadenylation signal. A subset of recessive mutations caused abnormal INS transcription, including the deletion of the C1 and E1 cis regulatory elements, or three different single base-pair substitutions in a CC dinucleotide sequence located between E1 and A1 elements. In keeping with an earlier and more severe beta-cell defect, patients with recessive INS mutations had a lower birth weight (-3.2 SD score vs. -2.0 SD score) and were diagnosed earlier (median 1 week vs. 10 weeks) compared to those with dominant INS mutations. Mutations in the insulin gene can therefore result in neonatal diabetes as a result of two contrasting pathogenic mechanisms. Moreover, the recessively inherited mutations provide a genetic demonstration of the essential role of multiple sequence elements that regulate the biosynthesis of insulin in man
Outcomes of obstructed abdominal wall hernia: results from the UK national small bowel obstruction audit
Background:
Abdominal wall hernia is a common surgical condition. Patients may present in an emergency with bowel obstruction, incarceration or strangulation. Small bowel obstruction (SBO) is a serious surgical condition associated with significant morbidity. The aim of this study was to describe current management and outcomes of patients with obstructed hernia in the UK as identified in the National Audit of Small Bowel Obstruction (NASBO).
Methods:
NASBO collated data on adults treated for SBO at 131 UK hospitals between January and March 2017. Those with obstruction due to abdominal wall hernia were included in this study. Demographics, co-morbidity, imaging, operative treatment, and in-hospital outcomes were recorded. Modelling for factors associated with mortality and complications was undertaken using Cox proportional hazards and multivariable regression modelling.
Results:
NASBO included 2341 patients, of whom 415 (17¡7 per cent) had SBO due to hernia. Surgery was performed in 312 (75¡2 per cent) of the 415 patients; small bowel resection was required in 198 (63¡5 per cent) of these operations. Non-operative management was reported in 35 (54 per cent) of 65 patients with a parastomal hernia and in 34 (32¡1 per cent) of 106 patients with an incisional hernia. The in-hospital mortality rate was 9¡4 per cent (39 of 415), and was highest in patients with a groin hernia (11¡1 per cent, 17 of 153). Complications were common, including lower respiratory tract infection in 16¡3 per cent of patients with a groin hernia. Increased age was associated with an increased risk of death (hazard ratio 1¡05, 95 per cent c.i. 1¡01 to 1¡10; P = 0¡009) and complications (odds ratio 1¡05, 95 per cent c.i. 1¡02 to 1¡09; P = 0¡001).
Conclusion:
NASBO has highlighted poor outcomes for patients with SBO due to hernia, highlighting the need for quality improvement initiatives in this group
National prospective cohort study of the burden of acute small bowel obstruction
Background
Small bowel obstruction is a common surgical emergency, and is associated with high levels of morbidity and mortality across the world. The literature provides little information on the conservatively managed group. The aim of this study was to describe the burden of small bowel obstruction in the UK.
Methods
This prospective cohort study was conducted in 131 acute hospitals in the UK between January and April 2017, delivered by trainee research collaboratives. Adult patients with a diagnosis of mechanical small bowel obstruction were included. The primary outcome was inâhospital mortality. Secondary outcomes included complications, unplanned intensive care admission and readmission within 30 days of discharge. Practice measures, including use of radiological investigations, water soluble contrast, operative and nutritional interventions, were collected.
Results
Of 2341 patients identified, 693 (29¡6 per cent) underwent immediate surgery (within 24 h of admission), 500 (21¡4 per cent) had delayed surgery after initial conservative management, and 1148 (49¡0 per cent) were managed nonâoperatively. The mortality rate was 6¡6 per cent (6¡4 per cent for nonâoperative management, 6¡8 per cent for immediate surgery, 6¡8 per cent for delayed surgery; P = 0¡911). The major complication rate was 14¡4 per cent overall, affecting 19¡0 per cent in the immediate surgery, 23¡6 per cent in the delayed surgery and 7¡7 per cent in the nonâoperative management groups (P < 0¡001). Cox regression found hernia or malignant aetiology and malnutrition to be associated with higher rates of death. Malignant aetiology, operative intervention, acute kidney injury and malnutrition were associated with increased risk of major complication.
Conclusion
Small bowel obstruction represents a significant healthcare burden. Patientâlevel factors such as timing of surgery, acute kidney injury and nutritional status are factors that might be modified to improve outcomes
Outcomes of obstructed abdominal wall hernia: results from the UK national small bowel obstruction audit
Background
Abdominal wall hernia is a common surgical condition. Patients may present in an emergency with bowel obstruction, incarceration or strangulation. Small bowel obstruction (SBO) is a serious surgical condition associated with significant morbidity. The aim of this study was to describe current management and outcomes of patients with obstructed hernia in the UK as identified in the National Audit of Small Bowel Obstruction (NASBO).
Methods
NASBO collated data on adults treated for SBO at 131 UK hospitals between January and March 2017. Those with obstruction due to abdominal wall hernia were included in this study. Demographics, coâmorbidity, imaging, operative treatment, and inâhospital outcomes were recorded. Modelling for factors associated with mortality and complications was undertaken using Cox proportional hazards and multivariable regression modelling.
Results
NASBO included 2341 patients, of whom 415 (17¡7 per cent) had SBO due to hernia. Surgery was performed in 312 (75¡2 per cent) of the 415 patients; small bowel resection was required in 198 (63¡5 per cent) of these operations. Nonâoperative management was reported in 35 (54 per cent) of 65 patients with a parastomal hernia and in 34 (32¡1 per cent) of 106 patients with an incisional hernia. The inâhospital mortality rate was 9¡4 per cent (39 of 415), and was highest in patients with a groin hernia (11¡1 per cent, 17 of 153). Complications were common, including lower respiratory tract infection in 16¡3 per cent of patients with a groin hernia. Increased age was associated with an increased risk of death (hazard ratio 1¡05, 95 per cent c.i. 1¡01 to 1¡10; P = 0¡009) and complications (odds ratio 1¡05, 95 per cent c.i. 1¡02 to 1¡09; P = 0¡001).
Conclusion
NASBO has highlighted poor outcomes for patients with SBO due to hernia, highlighting the need for quality improvement initiatives in this group
Outcomes following small bowel obstruction due to malignancy in the national audit of small bowel obstruction
Introduction
Patients with cancer who develop small bowel obstruction are at high risk of malnutrition and morbidity following compromise of gastrointestinal tract continuity. This study aimed to characterise current management and outcomes following malignant small bowel obstruction.
Methods
A prospective, multicentre cohort study of patients with small bowel obstruction who presented to UK hospitals between 16th January and 13th March 2017. Patients who presented with small bowel obstruction due to primary tumours of the intestine (excluding left-sided colonic tumours) or disseminated intra-abdominal malignancy were included. Outcomes included 30-day mortality and in-hospital complications. Cox-proportional hazards models were used to generate adjusted effects estimates, which are presented as hazard ratios (HR) alongside the corresponding 95% confidence interval (95% CI). The threshold for statistical significance was set at the level of PâŻâ¤âŻ0.05 a-priori.
Results
205 patients with malignant small bowel obstruction presented to emergency surgery services during the study period. Of these patients, 50 had obstruction due to right sided colon cancer, 143 due to disseminated intraabdominal malignancy, 10 had primary tumours of the small bowel and 2 patients had gastrointestinal stromal tumours. In total 100 out of 205 patients underwent a surgical intervention for obstruction. 30-day in-hospital mortality rate was 11.3% for those with primary tumours and 19.6% for those with disseminated malignancy. Severe risk of malnutrition was an independent predictor for poor mortality in this cohort (adjusted HR 16.18, 95% CI 1.86 to 140.84, pâŻ=âŻ0.012). Patients with right-sided colon cancer had high rates of morbidity.
Conclusions
Mortality rates were high in patients with disseminated malignancy and in those with right sided colon cancer. Further research should identify optimal management strategy to reduce morbidity for these patient groups
Impact of neoadjuvant chemotherapy on thrombus viability in patients with Wilms tumour and caval extension: systematic review with meta-analysis
BACKGROUND: Inferior vena cava (IVC) tumour thrombus in children with Wilms tumour is typically managed with neoadjuvant chemotherapy with the intention of achieving thrombus regression in order to minimize the risks associated with complex vascular surgery. METHODS: A systematic review of Medline and Embase databases was undertaken to identify all eligible studies with reference to thrombus viability in Wilms tumour index cases with caval/cardiac extension. A meta-analysis of proportions was utilized for pooled thrombus viability data across studies. Logistic regression was used to analyse the relationship between thrombus viability and duration of chemotherapy. RESULTS: Thirty-five eligible observational studies and case reports met inclusion criteria describing a total of 236 patients with thrombus viability data. The pooled proportion of patients with viable tumour thrombus after neoadjuvant chemotherapy was 0.53 (0.43â0.63). Logistic regression analysis of 54 patients receiving either a standard (4â6âweeks) or extended (more than 6âweeks) course of neoadjuvant chemotherapy resulted in an odds ratio of 3.14 (95 per cent c.i. 0.97 to 10.16), Pâ=â0.056, with extended course therapy trending towards viable tumour thrombus. CONCLUSION: Preoperative chemotherapy is successful in achieving non-viability of caval and cardiac thrombi in around 50 per cent of children, without added benefit from extended cycles of neoadjuvant chemotherapy. Risks versus benefits of extirpative vascular surgery must be considered, therefore, for these high-risk patients
- âŚ